Article info
PDFLetters
Rituximab versus oral cyclophosphamide for treatment of relapses of proliferative lupus nephritis: a clinical observational study
- Correspondence to Dr Gabriella Moroni, Divisione di Nefrologia e Dialisi—Padiglione Croff, Fondazione Ospedale Maggiore, Mangiagalli, Regina Elena, Via della Commenda 15, 20122 Milano, Italy; gmoroni{at}policlinico.mi.it
Citation
Rituximab versus oral cyclophosphamide for treatment of relapses of proliferative lupus nephritis: a clinical observational study
Publication history
- Accepted April 9, 2012
- First published May 14, 2012.
Online issue publication
April 13, 2016
Article Versions
- Previous version (13 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions